How GoodRx Is Making Heart Health Medication Affordable

How GoodRx Is Making Heart Health Medication Affordable

Lisinopril, carvedilol, amlodipine and atorvastatin are some of the generic medications that GoodRx offers for under $30.


GoodRx, a leading prescription savings platform, has launched a significant initiative to tackle cardiovascular disease in the US. The company now offers 30 key heart health medications for under $30 at more than 70,000 pharmacies nationwide. This effort marks a significant advancement in making healthcare more affordable and accessible, particularly for the nearly half of US adults dealing with conditions like coronary artery disease, high cholesterol and hypertension.

Cardiovascular disease is a top health concern in the US, posing a major challenge to both the healthcare system and individuals. The economic toll is enormous, with billions spent each year on treatments, hospital stays and emergency care. Yet, initiatives like GoodRx’s play a crucial role in easing access to vital medications, essential for managing heart diseases.

“Improving access to affordable medications is the most important thing we can do to improve Americans’ heart health. The second most important is ensuring access to helpful, accurate information,” said Karla Robinson, MD, medical editor at GoodRx, in a press release.

Related: Top 15 Cardiovascular Disease Drugs in 2023 by 2022 Sales Data

Understanding Cardiovascular Disease Trends

The US faces a worrying trend in cardiovascular disease, affecting a large part of the population. According to the Centres for Disease Control and Prevention (CDC), one person dies every 33 seconds in the US from cardiovascular disease. Aging, unhealthy lifestyles and genetics increase the risk of heart-related conditions. Despite medical advancements, the fight against these diseases emphasizes the need for prevention, early detection and effective management.

Cardiovascular diseases come with significant financial costs, including hospital care, medication and the impact of lost productivity due to illness or death. Between 2018 and 2019, heart disease cost the US about $239.9 billion, according to the CDC. The healthcare system struggles to provide care while controlling costs. That’s where GoodRx comes in by helping to make medications more affordable, reducing hospital visits and easing the economic pressure on healthcare.

GoodRx: Leading Change

GoodRx’s “The GoodRx Effect” report shows the program’s success, preventing an estimated 140,000 emergency visits and 110,000 hospitalizations from cardiovascular events. This underscores the vital role of affordable medication in improving health outcomes and preventing critical conditions.

GoodRx also offers discounts on generic medications essential for treating heart disease. Drugs like Lisinopril, metoprolol and amlodipine are available for under $30, offering savings up to 91 percent for some. These discounts are crucial for uninsured patients or those with high deductible plans.

Beyond savings, GoodRx aims to empower patients with knowledge. The GoodRx Heart Health Center, led by medical professionals like Dr. Robinson, provides valuable information on heart conditions, risk factors and treatments, emphasizing the importance of informed patients in managing their health.

“Knowledge is power, so we create easy-to-understand content that people can actually use so they are better equipped to minimize the risk of disease, find affordable medications, stick to their treatment plans and ultimately improve their overall health and well-being,” Robinson added.

GoodRx’s initiative is a vital step in combating the challenges of cardiovascular disease and healthcare costs. By improving access to medications and educating patients, GoodRx is reducing financial burdens and fostering better health outcomes. As healthcare evolves, such initiatives are essential in promoting a healthier future, showcasing the impact of innovation and compassion in addressing major health concerns.